TUMOR HISTOLOGY FOLLOWING INDUCTION CHEMOTHERAPY AND/OR HIGH-DOSE CHEMOTHERAPY AND ITS IMPACT ON THE OUTCOME OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA

被引：0
|
作者：
Hishiki, T. [1 ]
Horie, H. [2 ]
Higashimoto, Y. [1 ]
Yotsumoto, K. [1 ]
Komatsu, S. [1 ]
Okimoto, Y. [3 ]
Kakuda, H. [3 ]
Taneyamai, Y. [3 ]
Yoshida, H. [4 ]
Iwai, J. [1 ]
机构：
[1] Chiba Childrens Hosp, Dept Pediat Surg, Chiba, Japan
[2] Chiba Childrens Hosp, Dept Pathol, Chiba, Japan
[3] Chiba Childrens Hosp, Dept Hematol & Oncol, Chiba, Japan
[4] Chiba Univ, Grad Sch Med, Dept Pediat Surg, Chiba, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-348
引用
收藏
页码：S331 / S331
页数：1
相关论文
共 50 条
  • [21] High-dose chemotherapy in treatment of children with high-risk retinoblastoma
    Dolgopolov, I.
    Ushakova, T.
    Pimenov, R.
    Subbotina, N.
    Boyarshinov, V.
    Visochin, I.
    Mentkevich, G.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S293 - S293
  • [22] High-dose chemotherapy in high-risk primary breast cancer
    Schmid, P
    Possinger, K
    ONKOLOGIE, 2002, 25 (02): : 112 - 120
  • [23] Outcome and efficacy of reduced-dose craniospinal irradiation and high-dose chemotherapy for high-risk medulloblastomas
    Kagawa, Naoki
    Hashimoto, Naoya
    Chiba, Yasuyoshi
    Izumoto, Shuichi
    Hara, Junichi
    Ohta, Hideaki
    Ozono, Keiichi
    Yoshimine, Toshiki
    NEURO-ONCOLOGY, 2008, 10 (03) : 484 - 485
  • [24] Hemorrhage During Induction Chemotherapy in Neuroblastoma: Additional Risk Factors in High-Risk Patients
    Voglino, Valerio
    Persano, Giorgio
    Crocoli, Alessandro
    Castellano, Aurora
    Serra, Annalisa
    Giordano, Ugo
    Natali, Gian Luigi
    Di Paolo, Pier Luigi
    Martucci, Cristina
    Stracuzzi, Alessandra
    Inserra, Alessandro
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [25] Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue
    Elzembely, Mahmoud M.
    Dahlberg, Ann E.
    Pinto, Navin
    Leger, Kasey J.
    Chow, Eric J.
    Park, Julie R.
    Carpenter, Paul A.
    Baker, K. Scott
    PEDIATRIC BLOOD & CANCER, 2019, 66 (01)
  • [26] High-dose chemotherapy as adjuvant treatment for high-risk primary breast cancer patients
    Bertuzzi, A
    Gullo, G
    Rimassa, L
    Castagna, L
    Santoro, A
    ANNALS OF ONCOLOGY, 2006, 17 (04) : 719 - 720
  • [27] Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients
    Greinix, HT
    Linkesch, W
    Seifert, M
    Kubista, E
    Czerwenka, K
    Elahi, F
    Zielinski, C
    Hoecker, P
    Steger, G
    Schulenburg, A
    Neumeister, G
    Rabitsch, W
    Jakesz, R
    Kalhs, P
    ACTA ONCOLOGICA, 2000, 39 (01) : 47 - 52
  • [28] Discouraging news for high-dose chemotherapy in high-risk breast cancer
    Pusztal, L
    Hortobagyi, GN
    LANCET, 1998, 352 (9127): : 501 - 502
  • [29] Predictors of survival in patients with high-risk neuroblastoma who failed tandem high-dose chemotherapy and autologous stem cell transplantation
    Yi, Eun Sang
    Son, Meong Hi
    Hyun, Ju Kyung
    Cho, Hee Won
    Ju, Hee Young
    Lee, Ji Won
    Yoo, Keon Hee
    Sung, Ki Woong
    Koo, Hong Hoe
    PEDIATRIC BLOOD & CANCER, 2020, 67 (02)
  • [30] Double high-dose chemotherapy with autologous stem cell transplantation in patients with high-risk neuroblastoma: A pilot study in a single center
    Sung, KW
    Yoo, KH
    Chung, EH
    Cho, EJ
    Jung, HL
    Koo, HH
    Lee, SK
    Lim, DH
    Kim, DY
    Kim, DW
    Kim, HR
    Kim, SW
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2002, 17 (04) : 537 - 543
12345